← StockMentionMap
AZTA — Azenta, Inc.
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about AZTA (2026-10-30)
- Azenta acquired SynPlexity and secured an exclusive license from Elegen to expand GENEWIZ gene synthesis capabilities.
- The company issued a press release and Form 8-K detailing these strategic investments and contractual arrangements.
AI summary of 5 headlines and post titles — mention data, not investment advice
| Bluesky | 3 | community |
| GDELT | 2 | news |
| Press Wires (PRN/GNW/BW) | 1 | press |
| SEC EDGAR 8-K | 1 | filings |
Open the live map →